U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213466) titled 'Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder' on Sept. 23.
Brief Summary: The goal of this clinical trial is to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss, and to study the effect of individualized guided medication in patients with bipolar disorder ages 18-65. The main questions it aims to answer are:
* Can the investigators compare the distribution of obesity characteristics (hungry brain, hungry gut, emotional hunger) between bipolar patients and non-bipolar participants (comparing from IRB #24-002375)?
* Can t...